Ansell Ltd
Company Profile
Business description
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Contact
678 Victoria Street
Level 3
Richmond
MelbourneVIC3121
AUST: +61 392707222
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
15,724
Stocks News & Analysis
stocks
10 best US growth stocks to buy for the long term
stocks
Higher fair value for overvalued ASX tech share
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,102.10 | 11.70 | 0.13% |
CAC 40 | 7,834.61 | 18.98 | -0.24% |
DAX 40 | 23,487.07 | 152.34 | -0.64% |
Dow JONES (US) | 46,315.27 | 172.85 | 0.37% |
FTSE 100 | 9,224.89 | 8.22 | 0.09% |
HKSE | 26,344.14 | 200.96 | -0.76% |
NASDAQ | 22,631.48 | 160.75 | 0.72% |
Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
NZX 50 Index | 13,141.54 | 90.12 | -0.68% |
S&P 500 | 6,664.36 | 32.40 | 0.49% |
S&P/ASX 200 | 8,810.90 | 11.40 | 0.13% |
SSE Composite Index | 3,828.58 | 8.49 | 0.22% |